Gossamer Bio(GOSS) Seeking Alpha·2025-05-16 01:30Core Viewpoint - Gossamer Bio, Inc. reported its Q1 2025 financial results and provided a corporate update during the earnings call, highlighting key developments and future outlooks for the company [3]. Financial Results - The earnings call was initiated by Bryan Giraudo, the Chief Financial Officer and Chief Operating Officer, who presented the financial results for the first quarter of 2025 [2][3]. - Gossamer Bio issued a press release earlier in the day detailing its financial performance and corporate updates [3]. Management Team - The call featured key members of the management team, including Faheem Hasnain (Founder, Chairman, and CEO), Dr. Richard Aranda (Chief Medical Officer), Caryn Peterson (EVP, Regulatory Affairs), and Bob Smith (Chief Commercial Officer) [3]. Forward-Looking Statements - The management cautioned that the call would include forward-looking statements, which are subject to risks and uncertainties that could cause actual results to differ materially from those projected [4][5].